Clinical Trial Alerts – June 2022

Cystic Fibrosis Foundation issued the following clinical trial alerts on June 14th: Study of Trikafta® in people with CF ages 12 years and older who have partial function CFTR mutations […]

CFFC Facebook Posts – May 2022 – Part 2

05/16/2022 – Artificial cell membrane channels composed of DNA can be opened and locked with a key – This research was not specifically geared to CF but artificially created channels […]

CFFC Facebook Posts – May 2022 – Part 1

05/01/2022 – Cystic Fibrosis Around the World: The Kingdom of Jordan – Another flashback to Gunnar Esiason’s series about CF experiences on other countries. This one has a nice tie […]

Adapting to Post COVID Schools

School and CF have always been a challenging combination. The COVID-19 pandemic – and the recovery – added twists to that formula. The Cystic Fibrosis Foundation (CFF) has updated their […]

2022 Kit Taylor Memorial Lecture

The Kit Taylor Memorial Fund brought us another informative evening through Dr. Jennifer Taylor-Cousar’s presentation entitled “CF Therapeutics: Great Strides & Future Directions.” Dr. Taylor-Cousar is the Medical Director of […]

CFFC Facebook Posts – April 2022 – Part 1

04/01/2022 – PMPRB court case outcome great news for cystic fibrosis – This article is specific to Canada; however, the subject is relevant to the current discussions in the US […]

Clinical Trial Alerts – April 2022

Cystic Fibrosis Foundation issued the following clinical trial alerts in April. April 6, 2022 Study of 4D-710 in Adults with Cystic Fibrosis Status: Enrolling Description: This study will test the […]